Location History:
- Patterson, NY (US) (1997)
- San Diego, CA (US) (2010)
- Irving, CA (US) (2018)
- Dallas, TX (US) (1995 - 2021)
- Austin, TX (US) (2022)
Company Filing History:
9 out of 712 
8 out of 5,463 
3 out of 1,187 
Years Active: 1995-2022
Title: Bruce A. Beutler: A Pioneer in Cancer Immunotherapy
Introduction: Bruce A. Beutler is a distinguished scientist and inventor based in Dallas, TX, with a remarkable portfolio of 19 patents. His groundbreaking work, particularly in the field of cancer therapy and immunology, has substantially contributed to advancements in medical science.
Latest Patents: Among Beutler's latest innovations are two noteworthy patents. The first focuses on "Compositions and methods for cancer therapy," which relates to compositions and methods for cancer immunotherapy and promotes hematopoietic recovery following treatments like chemotherapy or irradiation. The second patent, titled "Diprovocims: a new and potent class of TLR agonists," discloses a diprovocim compound that exhibits immune-adjuvant properties. This compound is notable for its distinct structural composition, which differs from existing TLR1/TLR2 lipoprotein agonists and synthetic TLR agonists, making it innovative in its ease of preparation and modification.
Career Highlights: Beutler’s career is marked by significant contributions in high-profile institutions such as The Rockefeller University and the University of Texas System. His research has propelled new frontiers in understanding immune responses and cancer treatment mechanisms.
Collaborations: Throughout his career, Bruce A. Beutler has collaborated with prominent figures in the scientific community, including Anthony Cerami and Stephen D. Wolpe. These collaborations have further enriched his research portfolio and led to important scientific discoveries.
Conclusion: Bruce A. Beutler's contributions to the fields of cancer therapy and immunology through his patents and collaborative efforts exemplify the spirit of innovation and dedication to improving healthcare. His continued research and inventions will undoubtedly pave the way for future advancements in medical treatment and understanding of immune processes.